Publications (15) Publications de ANA VALLEJO DE LA CUEVA

2024

  1. The pupillary dilation reflex to a nociceptive stimulus as a tool for analgesia management: A diagnostic study

    Australian Critical Care, Vol. 37, Núm. 2, pp. 230-235

2023

  1. Pupillary dilation reflex and behavioural pain scale: Study of diagnostic test

    Intensive and Critical Care Nursing, Vol. 74

  2. The Lysyl Oxidase G473A Polymorphism Exacerbates Oral Cancer Development in Humans and Mice

    International Journal of Molecular Sciences, Vol. 24, Núm. 11

2021

  1. Platelet lysate nebulization protocol for the treatment of covid‐19 and its sequels: Proof of concept and scientific rationale

    International Journal of Molecular Sciences, Vol. 22, Núm. 4, pp. 1-18

  2. Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study

    The Lancet Respiratory Medicine, Vol. 9, Núm. 3, pp. 239-250

2019

  1. Bening pneumoperitoneum in patient trying non invasive mechanical ventilation and gastrostomy

    Medicina Intensiva, Vol. 43, Núm. 4, pp. 258

2018

  1. A polymorphism in the lysyl oxidase propeptide domain accelerates carcinogen-induced cancer

    Carcinogenesis, Vol. 39, Núm. 7, pp. 921-930

2016

  1. A truncated phosphorylated p130Cas substrate domain is sufficient to drive breast cancer growth and metastasis formation in vivo

    Tumor Biology, Vol. 37, Núm. 8, pp. 10665-10673

  2. Improved intensive patient prognosis by earlier activation of rapid response teams and timely response

    Clinical Practice, Vol. 13, Núm. 2, pp. 51-57

2015

  1. Optimizing the dosing regimen of linezolid in critically ill septic patients undergoing continuous hemodiafiltration using a pharmacokinetic/pharmacodynamic analysis and Monte Carlo simulation

    Intensive Care Medicine Experimental

2013

  1. Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells

    Pharmacological Research, Vol. 72, pp. 61-68

  2. Combined 5-FU and ChoKα Inhibitors as a New Alternative Therapy of Colorectal Cancer: Evidence in Human Tumor-Derived Cell Lines and Mouse Xenografts

    PLoS ONE, Vol. 8, Núm. 6

  3. Intraventricular hemorrhage treated with intraventricular fibrinolysis. A 10-year experience

    Medicina Intensiva, Vol. 37, Núm. 2, pp. 61-66

2012

  1. Acid ceramidase as a chemotherapeutic target to overcome resistance to the antitumoral effect of choline kinase α inhibition

    Current Cancer Drug Targets, Vol. 12, Núm. 6, pp. 617-624

2009

  1. Estapedectomía, otitis media y meningitis recidivante

    Medicina Clinica